These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 18836944)

  • 1. New cardiovascular risk markers: the race is on, but are there any winners?
    Røsjø H; Omland T
    Scand J Clin Lab Invest; 2008; 68(8):673-7. PubMed ID: 18836944
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of selected aromatic amino acids in biological systems.
    Krzyściak W
    Acta Biochim Pol; 2011; 58(4):461-6. PubMed ID: 22175049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mysteries of lipoprotein(a) and cardiovascular disease revisited.
    Kiechl S; Willeit J
    J Am Coll Cardiol; 2010 May; 55(19):2168-70. PubMed ID: 20447544
    [No Abstract]   [Full Text] [Related]  

  • 4. Indoleamine 2,3-dioxygenase and foxp3 expression in skin rejection of human hand allografts.
    Hautz T; Brandacher G; Zelger B; Müller HG; Lee AW; Fuchs D; Margreiter R; Schneeberger S
    Transplant Proc; 2009 Mar; 41(2):509-12. PubMed ID: 19328914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase.
    Rafice SA; Chauhan N; Efimov I; Basran J; Raven EL
    Biochem Soc Trans; 2009 Apr; 37(Pt 2):408-12. PubMed ID: 19290871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bioactive isoprostanes. New markers of oxidative stress and inflammation-related diseases].
    Basu S; Helmersson J
    Lakartidningen; 2009 Jan 28-Feb 3; 106(5):274-8. PubMed ID: 19271455
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on "Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression".
    Sørensen RB; thor Straten P; Andersen MH
    J Immunol; 2009 Nov; 183(10):6040. PubMed ID: 19890063
    [No Abstract]   [Full Text] [Related]  

  • 8. Uric acid and cardiovascular risk.
    Parmar MS
    N Engl J Med; 2009 Jan; 360(5):539; author reply 540-1. PubMed ID: 19186310
    [No Abstract]   [Full Text] [Related]  

  • 9. [Indoleamine 2,3-dioxygenase expression in breast cancer patients during chemotherapy].
    Sakurai K; Enomoto K; Kitajima A; Tani M; Amano S; Shiono M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2265-7. PubMed ID: 19106591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of elevated serum alanine aminotransferase levels: think outside the liver.
    Ioannou GN
    Gastroenterology; 2008 Dec; 135(6):1851-4. PubMed ID: 19007778
    [No Abstract]   [Full Text] [Related]  

  • 11. Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.
    Yue EW; Douty B; Wayland B; Bower M; Liu X; Leffet L; Wang Q; Bowman KJ; Hansbury MJ; Liu C; Wei M; Li Y; Wynn R; Burn TC; Koblish HK; Fridman JS; Metcalf B; Scherle PA; Combs AP
    J Med Chem; 2009 Dec; 52(23):7364-7. PubMed ID: 19507862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and related biomarkers in cardiovascular disease.
    Bartunek J; Vanderheyden M
    Biomark Med; 2012 Feb; 6(1):1-3. PubMed ID: 22296190
    [No Abstract]   [Full Text] [Related]  

  • 13. Indoleamine 2,3-dioxygenase expression in gestational trophoblastic disease: implications for development of immunotherapeutic approaches.
    Sebire NJ; Fisher RA; Williams S; Prendergast G; Savage P; Seckl M
    J Reprod Med; 2008 Oct; 53(10):789-92. PubMed ID: 19004406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome.
    Chamuleau ME; van de Loosdrecht AA; Hess CJ; Janssen JJ; Zevenbergen A; Delwel R; Valk PJ; Löwenberg B; Ossenkoppele GJ
    Haematologica; 2008 Dec; 93(12):1894-8. PubMed ID: 19050070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Expression of indoleamine 2,3-dioxygenase (IDO) and accumulation of kynurenic acid in the pathogenesis of STZ-induced diabetic cataract in Wistar rats.
    Kanth VR; Lavanya K; Srinivas J; Raju TN
    Curr Eye Res; 2009 Apr; 34(4):274-81. PubMed ID: 19373575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans fatty acids and cardiovascular risk markers: does the source matter?
    Mensink RP; Nestel P
    Curr Opin Lipidol; 2009 Feb; 20(1):1-2. PubMed ID: 19106705
    [No Abstract]   [Full Text] [Related]  

  • 17. Pregnancy, indoleamine 2,3-dioxygenase (IDO) and chlamydial abortion: an unresolved paradox.
    Entrican G; Wattegedera S; Rocchi M; Wheelhouse N
    Vet Microbiol; 2009 Mar; 135(1-2):98-102. PubMed ID: 18945560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biobanks and the search for predictive biomarkers of local and systemic outcome in atherosclerotic disease.
    Hurks R; Peeters W; Derksen WJ; Hellings WE; Hoefer IE; Moll FL; de Kleijn DP; Pasterkamp G
    Thromb Haemost; 2009 Jan; 101(1):48-54. PubMed ID: 19132188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
    DelaRosa O; Lombardo E; Beraza A; Mancheño-Corvo P; Ramirez C; Menta R; Rico L; Camarillo E; García L; Abad JL; Trigueros C; Delgado M; Büscher D
    Tissue Eng Part A; 2009 Oct; 15(10):2795-806. PubMed ID: 19231921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low levels of serum asymmetric antibodies as a marker of threatened pregnancy.
    Barrientos G; Fuchs D; Schröcksnadel K; Ruecke M; Garcia MG; Klapp BF; Raghupathy R; Miranda S; Arck PC; Blois SM
    J Reprod Immunol; 2009 Jan; 79(2):201-10. PubMed ID: 19233480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.